INTERDIGITATING DENDRITIC CELL SARCOMA

Clinical trials for INTERDIGITATING DENDRITIC CELL SARCOMA explained in plain language.

Never miss a new study

Get alerted when new INTERDIGITATING DENDRITIC CELL SARCOMA trials appear

Sign up with your email to follow new studies for INTERDIGITATING DENDRITIC CELL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Immune therapy tested for rare, Tough-to-Treat cancers

Disease control Terminated

This study is testing a drug called pembrolizumab for people with rare, aggressive cancers of the immune system (like certain lymphomas and histiocyte/dendritic cell sarcomas) that have come back or stopped responding to standard treatments. The drug aims to help the body's own i…

Matched conditions: INTERDIGITATING DENDRITIC CELL SARCOMA

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

INTERDIGITATING DENDRITIC CELL SARCOMA

Get alerted when new INTERDIGITATING DENDRITIC CELL SARCOMA trials appear

Immune therapy tested for rare, Tough-to-Treat cancers